Balance Sheet
AssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

PureTech Health (PTCHF) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for PureTech Health (PTCHF) over the last 7 years, with Q2 2025 value amounting to $260.6 million.

  • PureTech Health's Cash & Equivalents changed N/A to $260.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $260.6 million, marking a year-over-year change of. This contributed to the annual value of $280.6 million for FY2024, which is 1421.46% down from last year.
  • Per PureTech Health's latest filing, its Cash & Equivalents stood at $260.6 million for Q2 2025.
  • Over the past 5 years, PureTech Health's Cash & Equivalents peaked at $465.7 million during Q4 2021, and registered a low of $149.9 million during Q4 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $280.6 million (2024), whereas its average is $296.8 million.
  • In the last 5 years, PureTech Health's Cash & Equivalents plummeted by 6781.97% in 2022 and then surged by 11829.03% in 2023.
  • Over the past 5 years, PureTech Health's Cash & Equivalents (Quarter) stood at $465.7 million in 2021, then crashed by 67.82% to $149.9 million in 2022, then skyrocketed by 118.29% to $327.1 million in 2023, then dropped by 14.21% to $280.6 million in 2024, then dropped by 7.14% to $260.6 million in 2025.
  • Its Cash & Equivalents was $260.6 million in Q2 2025, compared to $280.6 million in Q4 2024 and $327.1 million in Q4 2023.